Soliton Provides Special 510(k) and Commercialization Update
- Thursday, April 15, 2021, 7:13
- PR Newswire
- Add a comment
HOUSTON, April 15, 2021 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted its special 510(k) application…
About the Author
admin has written 20543 stories on this site.